Metastatic signet-ring cell carcinoma of the urinary bladder: A novel management approach to a rare tumour

Research output: Contribution to journalArticle

3 Scopus citations

Abstract

Primary signet-ring cell carcinoma (SRCC) of the urinary bladder, a variant of adenocarcinoma, is exceedingly rare and as a result no gold standard exists for its management. We report a case of primary SRCC of the bladder with recurrent metastases; we utilized an innovative diagnostic approach and the patient exhibited a treatment response to palliative FOLFOX-6 chemotherapy.

Original languageEnglish (US)
Pages (from-to)E204-E207
JournalJournal of the Canadian Urological Association
Volume9
Issue number3-4APRIL
DOIs
StatePublished - Apr 13 2015

Keywords

  • Bladder cancer
  • FOLFOX-6
  • Metastatic
  • Next generation sequencing
  • Signet-ring cell carcinoma

ASJC Scopus subject areas

  • Oncology
  • Urology

Fingerprint Dive into the research topics of 'Metastatic signet-ring cell carcinoma of the urinary bladder: A novel management approach to a rare tumour'. Together they form a unique fingerprint.

  • Cite this